Equities
Janus International shares drop 14% on weak outlook despite earnings beat
Company posts better-than-expected quarterly earnings but issues cautious full-year guidance, prompting a sharp selloff in shares.
Ceragon shares jump 4% after Q2 earnings beat
Israel-based telecom equipment maker posts better-than-expected quarterly results, lifting shares despite broader sector headwinds.
Legend Biotech shares gain 5% after earnings, revenue top estimates
Legend Biotech reported quarterly results that exceeded analyst expectations, lifting shares by 5% in premarket trading.
Autolus shares rise 3% after Q2 earnings beat, higher revenue outlook
Biotech firm Autolus reports better-than-expected second-quarter results and raises full-year revenue guidance, lifting shares by 3%.
Littelfuse appoints Plexus CEO Todd Kelsey to board
Littelfuse adds Todd Kelsey, CEO of Plexus, to its board of directors, expanding industry expertise in electronics manufacturing.
Stardust Power appoints V. Ray Rivers to board
Renewable energy firm Stardust Power adds former utility executive V. Ray Rivers to its board, signaling strategic expansion in solar and storage.
Bicara Therapeutics names new CEO, appoints CFO
Biotech firm Bicara Therapeutics appoints interim CEO and a new chief financial officer to strengthen leadership amid growth phase.
ZenaTech initiates in-house circuit board flight tests
Company advances toward self-sufficiency in avionics manufacturing with proprietary circuit board prototypes undergoing evaluation.
Enviri shares slip after Q2 loss, beat EBITDA target
Second-quarter loss narrows but misses revenue estimates as adjusted EBITDA exceeds expectations.
Vestis shares surge 8% after Q3 miss, cash flow outlook raised
Vestis reported weaker-than-expected third-quarter earnings but upgraded its full-year cash flow guidance, lifting shares despite the miss.
ATS shareholders re-elect directors, approve $100m buyback
Shareholders of ATS Corporation re-elected all board members and authorized a $100 million share repurchase program. The moves follow strong Q2 earnings and guidance upgrades.
Phio Pharmaceuticals granted U.S. patent allowance for PH-894
Patent allowance for PH-894, a preclinical candidate in oncology, follows prior regulatory approvals for Phio’s RNAi platform.
Invesco assets under management fall 0.9% to $2.45 trillion in July
Monthly decline reflects broader market trends as global equities and fixed income face mixed performance across regions.
CenterPoint Energy forecasts $5 billion in savings for Texas customers
Utility projects decade-long cost reductions through efficiency and infrastructure upgrades. Savings to be shared with ratepayers under state regulations.
NeurAxis posts 116% revenue growth in Q2 2026
AI-driven software firm NeurAxis reports second-quarter revenue surge, driven by enterprise demand and product expansion.
Parsons wins $40 million Army contract for electromagnetic warfare
Defense contractor Parsons secures a $40 million U.S. Army contract to develop electromagnetic warfare systems, expanding its role in military modernization efforts.
Duke Energy raises $1.75 bln via equity units offering
Utility secures capital through structured equity units priced at $1.75 billion, with proceeds to fund growth initiatives and balance sheet management.
Babcock & Wilcox wins 1GW turbine contract with Siemens Energy
Deal underscores growing demand for large-scale power generation solutions amid energy transition. Shares of Babcock & Wilcox rise on contract news.
Cardinal Health raises quarterly dividend to $0.5158 per share
Healthcare services firm increases payout by 3.9% from prior quarter, aligning with its capital return strategy.
Venture Global shares drop after revenue miss despite earnings beat
Stock falls 5% as revenue misses estimates while profit exceeds forecasts, reflecting investor scrutiny of growth trajectory.
JBS shares dip after adjusted earnings miss forecasts
Brazil-based meatpacker reports adjusted earnings below analyst expectations, prompting modest decline in stock price.
Huya shares drop on weak guidance despite narrower loss
Chinese live-streaming platform reports improved quarterly results but issues cautious revenue outlook, sending shares lower.
Elbit Systems shares drop 6% despite Q2 earnings beat
Defense contractor posts higher-than-expected Q2 profit but warns on future margins; shares fall on cautious outlook.
BioHarvest Sciences shares rise 11% on fragrance deal
Company secures major fragrance supply agreement, boosting investor confidence in BioHarvest Sciences' market position.